Electra Therapeutics Inc.
Clinical trials sponsored by Electra Therapeutics Inc., explained in plain language.
-
New drug trial offers hope for Tough-to-Treat blood cancers
Disease control Recruiting nowThis early-stage study is testing a new drug called ELA026 for adults with advanced T cell cancers that have returned or haven't responded to previous treatments. Researchers will first determine safe dosage levels, then expand to more participants to see how well the drug works.…
Phase: PHASE1 • Sponsor: Electra Therapeutics Inc. • Aim: Disease control
Last updated Apr 02, 2026 04:12 UTC
-
New antibody targets deadly immune storm in rare disease
Disease control Recruiting nowThis study is testing an investigational drug called ELA026 for people with secondary hemophagocytic lymphohistiocytosis (sHLH), a rare and life-threatening condition where the immune system becomes dangerously overactive. The main goals are to see if ELA026 is safe, if it can he…
Phase: PHASE2, PHASE3 • Sponsor: Electra Therapeutics Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC